Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy was underpowered

Detalles Bibliográficos
Autores principales: Ortiz, Alberto, Sanchez-Niño, Maria Dolores
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636096/
https://www.ncbi.nlm.nih.gov/pubmed/26586938
http://dx.doi.org/10.2147/DDDT.S93371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636096/
https://www.ncbi.nlm.nih.gov/pubmed/26586938
http://dx.doi.org/10.2147/DDDT.S93371

Ejemplares similares